Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer immunotherapy.

Juhua Zhou1, Yin Zhong

  • 1Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. juhua_zhou@nih.gov

Cellular & Molecular Immunology
|October 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular-Level Exploration of Pyrogenic Dissolved Organic Matter in Charcoal and Soot Produced Simultaneously by the Combustion of Rice Straw.

Environmental science & technology·2026
Same author

Establishing a transdisciplinary competency framework for interdisciplinary case management practice in long-term care: a participatory Delphi study.

Human resources for health·2026
Same author

Developing an <i>E. coli</i> heterologous expression system for characterizing a marine debrominase from <i>Roseobacter</i> sp.

Applied and environmental microbiology·2026
Same author

Mechanistic Insights into Anaerobic Biotransformation of Tris(2-Chloroethyl) Phosphate by Compound-Specific Stable Isotope Analysis and Quantum Chemical Calculations.

Environmental science & technology·2026
Same author

The moderating role of agency and belonging in the healthy aging framework: a momentary assessment study among older adults in Hong Kong.

Aging & mental health·2026
Same author

Dechlorination of mixed chlorinated organophosphate esters (V6 and TCEP) and associated reductive dehalogenase gene expression by <i>Dehalococcoides mccartyi</i>.

Applied and environmental microbiology·2026
Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026
Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026
Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026
Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026
Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026
Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026
See all related articles

Immunotherapy offers a promising avenue for advanced breast cancer treatment, exploring methods like antibody therapy, cancer vaccines, and T cell transfer. Further clinical trials are needed to confirm its effectiveness in curing breast cancer.

Area of Science:

  • Oncology
  • Immunology

Background:

  • Breast cancer is a significant global health challenge, particularly for invasive and metastatic forms where current treatments are limited.
  • While established therapies exist, they are often insufficient for advanced breast cancer, necessitating novel treatment strategies.

Purpose of the Study:

  • To review the current landscape and future potential of various breast cancer immunotherapy approaches.
  • To highlight the feasibility and promise of antibody-based, vaccine, adoptive T cell, and T cell receptor gene transfer immunotherapies.

Main Methods:

  • Review of existing literature on breast cancer immunotherapy modalities.
  • Analysis of the mechanisms and clinical potential of antibody-based therapy (e.g., trastuzumab), cancer vaccines, adoptive T cell transfer, and T cell receptor gene transfer.

Related Experiment Videos

Main Results:

  • Antibody therapy (trastuzumab) shows success but is limited to HER-2/neu over-expressing tumors (25-30%).
  • Cancer vaccines can induce anti-tumor immunity but not objective tumor regression.
  • Adoptive T cell transfer and T cell receptor gene transfer show feasibility for breast cancer treatment, with early promising results.

Conclusions:

  • Immunotherapy represents a potential breakthrough for advanced breast cancer, offering targeted treatment options.
  • T cell receptor gene transfer, exemplified by chimeric receptors targeting HER-2/neu, demonstrates significant promise.
  • Ongoing clinical trials are crucial to validate immunotherapy as a curative strategy for breast cancer.